Cognitive Impairment among People Who Use Heroin and Fentanyl: Findings from the Miami Adult Studies on HIV (MASH) Cohort

References

• Adams, L. M., T. E. Wilson, D. Merenstein, J. Milam, J. Cohen, E. T. Golub, A. Adedimeji, and J. A. Cook. 2018. Using the center for epidemiologic studies depression scale to assess depression in women with HIV and women at risk for HIV: Are somatic items invariant? Psychological Assessment 30 (1):97–105. doi:10.1037/pas0000456.
   PubMed Web of Science ®Google Scholar
• Apostolova, L. G., and J. L. Cummings. 2008. Neuropsychiatric manifestations in mild cognitive impairment: A systematic review of the literature. Dementia and Geriatric Cognitive Disorders 25 (2):115–26. doi:10.1159/000112509.
   PubMed Web of Science ®Google Scholar
• Apostolova, L. G., L. J. Di, E. L. Duffy, J. Brook, D. Elashoff, C. H. Tseng, L. Fairbanks, and J. L. Cummings. 2014. Risk factors for behavioral abnormalities in mild cognitive impairment and mild Alzheimer’s disease. Dementia and Geriatric Cognitive Disorders 37 (5–6):315–26. doi:10.1159/000351009.
   PubMed Web of Science ®Google Scholar
• Auyeung, T. W., T. Kwok, J. Lee, P. C. Leung, J. Leung, and J. Woo. 2008. Functional decline in cognitive impairment – the relationship between physical and cognitive function. Neuroepidemiology 31 (3):167–73. doi:10.1159/000154929.
   PubMed Web of Science ®Google Scholar
• Baldacchino, A., D. J. Balfour, F. Passetti, G. Humphris, and K. Matthews. 2012. Neuropsychological consequences of chronic opioid use: A quantitative review and meta-analysis. Neuroscience & Biobehavioral Reviews 36 (9):2056–68. doi:10.1016/j.neubiorev.2012.06.006.
   PubMed Web of Science ®Google Scholar
• Bassiony, M. M., U. M. Youssef, M. S. Hassan, G. M. Salah El-Deen, H. El-Gohari, M. Abdelghani, A. Abdalla, and D. H. Ibrahim. 2017. Cognitive impairment and tramadol dependence. Journal of Clinical Psychopharmacology 37 (1):61–66. doi:10.1097/JCP.0000000000000617.
   PubMed Web of Science ®Google Scholar
• Bryant, V. E., N. E. Whitehead, L. E. Burrell 2nd, V. M. Dotson, R. L. Cook, P. Malloy, K. Devlin, and R. A. Cohen. 2015. Depression and apathy among people living with HIV: Implications for treatment of HIV associated neurocognitive disorders. AIDS and Behavior 19 (8):1430–37. doi:10.1007/s10461-014-0970-1.
   PubMed Web of Science ®Google Scholar
• Byrd, D. A., R. P. Fellows, S. Morgello, D. Franklin, R. K. Heaton, R. Deutsch, J. H. Atkinson, D. B. Clifford, A. C. Collier, C. M. Marra, et al. 2011. Neurocognitive impact of substance use in HIV infection. JAIDS Journal of Acquired Immune Deficiency Syndromes 58 (2):154–62. doi:10.1097/QAI.0b013e318229ba41.
   PubMed Web of Science ®Google Scholar
• Canan, C. E., G. Chander, A. K. Monroe, K. A. Gebo, R. D. Moore, A. L. Agwu, G. C. Alexander, B. Lau, and H. I. V. Research Network. 2018. High-risk prescription opioid use among people living with HIV. JAIDS Journal of Acquired Immune Deficiency Syndromes 78 (3):283–90. doi:10.1097/QAI.0000000000001690.
   PubMed Web of Science ®Google Scholar
• Castellon, S. A., C. H. Hinkin, and H. F. Myers. 2000. Neuropsychiatric disturbance is associated with executive dysfunction in HIV-1 infection. Journal of the International Neuropsychological Society 6 (3):336–47. doi:10.1017/s1355617700633088.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. 2019. 2019 annual surveillance report of drug-related risks and outcomes — United States surveillance special report. Centers for Disease Control and Prevention, U.S. Department of Health and Human Services.
   Google Scholar
• Chilunda, V., T. M. Calderon, P. Martinez-Aguado, and J. W. Berman. 2019. The impact of substance abuse on HIV-mediated neuropathogenesis in the current ART era. Brain Research 1724:146426. doi:10.1016/j.brainres.2019.146426.
   PubMed Web of Science ®Google Scholar
• Clifford, D. B. 2017. HIV-associated neurocognitive disorder. Current Opinion in Infectious Diseases 30 (1):117–22. doi:10.1097/QCO.0000000000000328.
   PubMed Web of Science ®Google Scholar
• Compton, W. M., C. M. Jones, G. T. Baldwin, and D. L. Longo. 2016. Relationship between nonmedical prescription-opioid use and heroin use. New England Journal of Medicine 374 (2):154–63. doi:10.1056/NEJMra1508490.
   PubMed Web of Science ®Google Scholar
• Cunningham, C. O. 2018. Opioids and HIV infection: From pain management to addiction treatment. Topics in Antiviral Medicine 25 (4):143–46.
   PubMedGoogle Scholar
• Dagenais-Lussier, X., A. Mouna, J. P. Routy, C. Tremblay, R. P. Sekaly, M. El-Far, and J. Grevenynghe. 2015. Current topics in HIV-1 pathogenesis: The emergence of deregulated immuno-metabolism in HIV-infected subjects. Cytokine & Growth Factor Reviews 26 (6):603–13. doi:10.1016/j.cytogfr.2015.09.001.
   PubMed Web of Science ®Google Scholar
• de Siqueira, A. S., J. E. Yokomizo, W. Jacob-Filho, M. S. Yassuda, and I. Aprahamian. 2017. Review of decision-making in game tasks in elderly participants with alzheimer disease and mild cognitive impairment. Dementia and Geriatric Cognitive Disorders 43 (1–2):81–88. doi:10.1159/000455120.
   PubMed Web of Science ®Google Scholar
• Dezman, Z. D. W., W. Felemban, L. J. Bontempo, and E. D. Wish. 2020. Evidence of fentanyl use is common and frequently missed in a cross-sectional study of emergency department patients in Baltimore, Maryland. Clinical Toxicology 58 (1):59–61. doi:10.1080/15563650.2019.1605078.
   PubMed Web of Science ®Google Scholar
• Dutta, R., and S. Roy. 2012. Mechanism(s) involved in opioid drug abuse modulation of HAND. Current HIV Research 10 (5):469–77. doi:10.2174/157016212802138805.
   PubMed Web of Science ®Google Scholar
• Eggers, C., G. Arendt, K. Hahn, I. W. Husstedt, M. Maschke, E. Neuen-Jacob, M. Obermann, T. Rosenkranz, E. Schielke, and E. Straube. 2017. HIV-1-associated neurocognitive disorder: Epidemiology, pathogenesis, diagnosis, and treatment. Journal of Neurology 264 (8):1715–27. doi:10.1007/s00415-017-8503-2.
   PubMed Web of Science ®Google Scholar
• Fandel, G., T. Gál, and T. Hanne. 1997. Multiple criteria decision making: Proceedings of the Twelfth International Conference, Lecture notes in economics and mathematical systems. New York: Springer-Verlag.
   Google Scholar
• Folstein, M. F., S. E. Folstein, and P. R. McHugh. 1975. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research 12 (3):189–98. doi:10.1016/0022-3956(75)90026-6.
   PubMed Web of Science ®Google Scholar
• Forrester, S. N., J. J. Gallo, G. S. Smith, and J. M. Leoutsakos. 2016. Patterns of neuropsychiatric symptoms in mild cognitive impairment and risk of dementia. The American Journal of Geriatric Psychiatry 24 (2):117–25. doi:10.1016/j.jagp.2015.05.007.
   PubMed Web of Science ®Google Scholar
• Gladden, R. M., P. Martinez, and P. Seth. 2016. Fentanyl law enforcement submissions and increases in synthetic opioid-involved overdose deaths - 27 states, 2013-2014. MMWR. Morbidity and Mortality Weekly Report 65 (33):837–43. doi:10.15585/mmwr.mm6533a2.
   PubMed Web of Science ®Google Scholar
• Grant, B. F., R. B. Goldstein, S. M. Smith, J. Jung, H. Zhang, S. P. Chou, R. P. Pickering, W. J. Ruan, B. Huang, T. D. Saha, et al. 2015. The Alcohol Use Disorder and Associated Disabilities Interview Schedule-5 (AUDADIS-5): Reliability of substance use and psychiatric disorder modules in a general population sample. Drug and Alcohol Dependence 148:27–33. doi:10.1016/j.drugalcdep.2014.11.026.
   PubMed Web of Science ®Google Scholar
• Griswold, M. K., P. R. Chai, A. J. Krotulski, M. Friscia, B. Chapman, E. W. Boyer, B. K. Logan, and K. M. Babu. 2018. Self-identification of nonpharmaceutical fentanyl exposure following heroin overdose. Clinical Toxicology 56 (1):37–42. doi:10.1080/15563650.2017.1339889.
   PubMed Web of Science ®Google Scholar
• Hauser, K. F., S. Fitting, S. M. Dever, E. M. Podhaizer, and P. E. Knapp. 2012. Opiate drug use and the pathophysiology of neuroAIDS. Current HIV Research 10 (5):435–52. doi:10.2174/157016212802138779.
   PubMed Web of Science ®Google Scholar
• Heishman, S. J., B. A. Kleykamp, and E. G. Singleton. 2010. Meta-analysis of the acute effects of nicotine and smoking on human performance. Psychopharmacology (Berl) 210 (4):453–69. doi:10.1007/s00213-010-1848-1.
   PubMed Web of Science ®Google Scholar
• Higashikawa, Y., and S. Suzuki. 2008. Studies on 1-(2-phenethyl)-4-(N-propionylanilino)piperidine (fentanyl) and its related compounds. VI. Structure-analgesic activity relationship for fentanyl, methyl-substituted fentanyls and other analogues. Forensic Toxicology 26 (1):1–5. doi:10.1007/s11419-007-0039-1.
   Web of Science ®Google Scholar
• Hill, N. L., C. McDermott, J. Mogle, E. Munoz, N. DePasquale, R. Wion, and E. Whitaker. 2017. Subjective cognitive impairment and quality of life: A systematic review. International Psychogeriatrics 29 (12):1965–77. doi:10.1017/S1041610217001636.
   PubMed Web of Science ®Google Scholar
• Ismail, Z., T. K. Rajji, and K. I. Shulman. 2010. Brief cognitive screening instruments: An update. International Journal of Geriatric Psychiatry 25 (2):111–20. doi:10.1002/gps.2306.
   PubMed Web of Science ®Google Scholar
• Joska, J. A., J. Witten, K. G. Thomas, C. Robertson, M. Casson-Crook, H. Roosa, J. Creighton, J. Lyons, J. McArthur, and N. C. Sacktor. 2016. A comparison of five brief screening tools for HIV-associated neurocognitive disorders in the USA and south africa. AIDS and Behavior 20 (8):1621–31. doi:10.1007/s10461-016-1316-y.
   PubMed Web of Science ®Google Scholar
• Lindbergh, C. A., R. K. Dishman, and L. S. Miller. 2016. Functional disability in mild cognitive impairment: A systematic review and meta-analysis. Neuropsychology Review 26 (2):129–59. doi:10.1007/s11065-016-9321-5.
   PubMed Web of Science ®Google Scholar
• Maglione, M. A., R. Laura, C. Christine, G. S. Azhar, S. Nima, S. Mimi, E. J. Maksabedian Hernandez, R. M. Shanman, and H. Susanne. 2020. Effects of medication-assisted treatment (mat) for opioid use disorder on functional outcomes: A systematic review. Rand Health Quarterly 8 (4):RR-2108-OSD.
   PubMedGoogle Scholar
• Mars, S. G., J. N. Fessel, P. Bourgois, F. Montero, G. Karandinos, and D. Ciccarone. 2015. Heroin-related overdose: The unexplored influences of markets, marketing and source-types in the United States. Social Science & Medicine 140:44–53. doi:10.1016/j.socscimed.2015.06.032.
   PubMed Web of Science ®Google Scholar
• Martin, E. M., K. Keutmann, J. S. Fogel, P. M. Maki, R. Gonzalez, J. Vassileva, L. H. Rubin, and D. Hardy. 2018. Verbal and spatial working memory among drug-using HIV-infected men and women. Journal of Neurovirology 24 (4):488–97. doi:10.1007/s13365-018-0639-z.
   PubMed Web of Science ®Google Scholar
• Mazhari, S., Z. Keshvari, A. Sabahi, and S. Mottaghian. 2015. Assessment of cognitive functions in methadone maintenance patients. Addiction & Health 7 (3–4):109–16.
   PubMedGoogle Scholar
• McGinnis, K. A., A. C. Justice, K. L. Kraemer, R. Saitz, K. J. Bryant, and D. A. Fiellin. 2013. Comparing alcohol screening measures among HIV-infected and -uninfected men. Alcoholism: Clinical and Experimental Research 37 (3):435–42. doi:10.1111/j.1530-0277.2012.01937.x.
   PubMed Web of Science ®Google Scholar
• Meade, C. S., M. Addicott, A. L. Hobkirk, S. L. Towe, N. K. Chen, S. Sridharan, and S. A. Huettel. 2018. Cocaine and HIV are independently associated with neural activation in response to gain and loss valuation during economic risky choice. Addiction Biology 23 (2):796–809. doi:10.1111/adb.12529.
   PubMed Web of Science ®Google Scholar
• Meade, C. S., N. A. Conn, L. M. Skalski, and S. A. Safren. 2011. Neurocognitive impairment and medication adherence in HIV patients with and without cocaine dependence. Journal of Behavioral Medicine 34 (2):128–38. doi:10.1007/s10865-010-9293-5.
   PubMed Web of Science ®Google Scholar
• Mickey, R. M., and S. Greenland. 1989. The impact of confounder selection criteria on effect estimation. American Journal of Epidemiology 129 (1):125–37. doi:10.1093/oxfordjournals.aje.a115101.
   PubMed Web of Science ®Google Scholar
• Ornstein, T. J., J. L. Iddon, A. M. Baldacchino, B. J. Sahakian, M. London, B. J. Everitt, and T. W. Robbins. 2000. Profiles of cognitive dysfunction in chronic amphetamine and heroin abusers. Neuropsychopharmacology 23 (2):113–26. doi:10.1016/S0893-133X(00)00097-X.
   PubMed Web of Science ®Google Scholar
• Patnode, C. D., Perdue, L. A., Rossom, R. C., Rushkin, M. C., Redmond, N., Thomas, R. G., and Lin, J. S. 2020. Screening for Cognitive Impairment in Older Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA 323(8):764–785. doi:10.1001/jama.2019.22258
   PubMed Web of Science ®Google Scholar
• Radloff, L. S. 2016. The CES-D Scale. Applied Psychological Measurement 1 (3):385–401. doi:10.1177/014662167700100306.
   Google Scholar
• Rao, V. R., A. P. Ruiz, and V. R. Prasad. 2014. Viral and cellular factors underlying neuropathogenesis in HIV associated neurocognitive disorders (HAND). AIDS Research and Therapy 11 (1):13. doi:10.1186/1742-6405-11-13.
   PubMed Web of Science ®Google Scholar
• Rapeli, P., C. Fabritius, H. Kalska, and H. Alho. 2011. Cognitive functioning in opioid-dependent patients treated with buprenorphine, methadone, and other psychoactive medications: Stability and correlates. BMC Clinical Pharmacology 11 (1):13. doi:10.1186/1472-6904-11-13.
   PubMedGoogle Scholar
• Rapeli, P., R. Kivisaari, T. Autti, S. Kahkonen, V. Puuskari, O. Jokela, and H. Kalska. 2006. Cognitive function during early abstinence from opioid dependence: A comparison to age, gender, and verbal intelligence matched controls. BMC Psychiatry 6 (1):9. doi:10.1186/1471-244X-6-9.
   PubMed Web of Science ®Google Scholar
• Sacktor, N., R. L. Skolasky, E. Seaberg, C. Munro, J. T. Becker, E. Martin, A. Ragin, A. Levine, and E. Miller. 2016. Prevalence of HIV-associated neurocognitive disorders in the Multicenter AIDS Cohort Study. Neurology 86 (4):334–40. doi:10.1212/WNL.0000000000002277.
   PubMed Web of Science ®Google Scholar
• Saloner, R., and L. A. Cysique. 2017. HIV-associated neurocognitive disorders: A global perspective. Journal of the International Neuropsychological Society 23 (9–10):860–69. doi:10.1017/S1355617717001102.
   PubMed Web of Science ®Google Scholar
• Seth, P., L. Scholl, R. A. Rudd, and S. Bacon. 2018. Overdose deaths involving opioids, cocaine, and psychostimulants - United States, 2015-2016. MMWR. Morbidity and Mortality Weekly Report 67 (12):349–58. doi:10.15585/mmwr.mm6712a1.
   PubMed Web of Science ®Google Scholar
• Sheth, S. A., N. C. Chandra, and R. Y. Mehta. 2018. Cognition and opioid substitution therapy adherence in patients with opioid dependence. Journal of Clinical and Diagnostic Research 12 (5):Vc1–Vc5. doi:10.7860/Jcdr/2018/34600.11455.
   Web of Science ®Google Scholar
• Smith, J. L., R. P. Mattick, S. D. Jamadar, and J. M. Iredale. 2014. Deficits in behavioural inhibition in substance abuse and addiction: A meta-analysis. Drug and Alcohol Dependence 145:1–33. doi:10.1016/j.drugalcdep.2014.08.009.
   PubMed Web of Science ®Google Scholar
• Spencer, R. J., C. R. Wendell, P. P. Giggey, L. I. Katzel, D. M. Lefkowitz, E. L. Siegel, and S. R. Waldstein. 2013. Psychometric limitations of the Mini-Mental State Examination among nondemented older adults: An evaluation of neurocognitive and magnetic resonance imaging correlates. Experimental Aging Research 39 (4):382–97. doi:10.1080/0361073X.2013.808109.
   PubMed Web of Science ®Google Scholar
• Tsoi, K. K., J. Y. Chan, H. W. Hirai, S. Y. Wong, and T. C. Kwok. 2015. Cognitive tests to detect dementia: A systematic review and meta-analysis. JAMA Internal Medicine 175 (9):1450–58. doi:10.1001/jamainternmed.2015.2152.
   PubMed Web of Science ®Google Scholar
• van Steenbergen, H., M. Eikemo, and S. Leknes. 2019. The role of the opioid system in decision making and cognitive control: A review. Cognitive, Affective & Behavioral Neuroscience 19 (3):435–58. doi:10.3758/s13415-019-00710-6.
   PubMed Web of Science ®Google Scholar
• Volpe, D. A., G. A. McMahon Tobin, R. D. Mellon, A. G. Katki, R. J. Parker, T. Colatsky, T. J. Kropp, and S. L. Verbois. 2011. Uniform assessment and ranking of opioid mu receptor binding constants for selected opioid drugs. Regulatory Toxicology and Pharmacology 59 (3):385–90. doi:10.1016/j.yrtph.2010.12.007.
   PubMed Web of Science ®Google Scholar
• Vowles, K. E., M. L. McEntee, P. S. Julnes, T. Frohe, J. P. Ney, and D. N. van der Goes. 2015. Rates of opioid misuse, abuse, and addiction in chronic pain: A systematic review and data synthesis. Pain 156 (4):569–76. doi:10.1097/01.j.pain.0000460357.01998.f1.
   PubMed Web of Science ®Google Scholar
• Walker, K. A., and G. G. Brown. 2018. HIV-associated executive dysfunction in the era of modern antiretroviral therapy: A systematic review and meta-analysis. Journal of Clinical and Experimental Neuropsychology 40 (4):357–76. doi:10.1080/13803395.2017.1349879.
   PubMed Web of Science ®Google Scholar
• Wang, G. Y., T. A. Wouldes, and B. R. Russell. 2013. Methadone maintenance treatment and cognitive function: A systematic review. Current Drug Abuse Reviews 6 (3):220–30. doi:10.2174/18744737112059990020.
   PubMedGoogle Scholar